These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 8399795)

  • 1. Erythrocyte Li+i-Na+o countertransport in the newborn.
    Agam G; Deutsch I; Karplus M; Livne AA
    Biol Neonate; 1993; 64(1):13-7. PubMed ID: 8399795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythrocyte sodium-lithium countertransport in diabetic children: 12 months development and relationship with familial hypertension].
    Guarena C; Boero R; Quarello F; Cerruti F; Rolando B; Sacchetti C; Rosati C; Iadarola G; Piccoli G
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1205-7. PubMed ID: 1482260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte Li-Na countertransport in uremic patients: effect of urea.
    Sun YF; Tsai CJ; Hsieh CC; Lau YT
    Chin J Physiol; 1996; 39(3):177-81. PubMed ID: 8955564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte sodium-lithium countertransport and proliferative diabetic retinopathy.
    Lopes de Faria JM; Silveira LA; Morgano M; Pavin EJ; Lopes de Faria JB
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1482-5. PubMed ID: 10798666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiol group control of sodium-lithium countertransport kinetics in uraemia: evidence of a membrane abnormality affected by haemodialysis.
    Rutherford PA; Thomas TH; O'Kelly J; West IC; Wilkinson R
    Nephron; 1996; 72(2):184-8. PubMed ID: 8684524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
    Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
    Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
    Siebers RW; Maling TJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na(+)-H+ and Na(+)-Li+ exchange are mediated by the same membrane transport protein in human red blood cells: an NMR investigation.
    Chi Y; Mo S; Mota de Freitas D
    Biochemistry; 1996 Sep; 35(38):12433-42. PubMed ID: 8823178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein beta3-subunit gene variant, blood pressure and erythrocyte sodium/lithium countertransport in essential hypertension.
    Poch E; González-Núñez D; Compte M; De la Sierra A
    Br J Biomed Sci; 2002; 59(2):101-4. PubMed ID: 12113397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparate effects of weight loss on insulin sensitivity and erythrocyte sodium-lithium countertransport activity.
    Wolpert HA; Steen SN; Istfan NW; Simonson DC
    Am J Hypertens; 1992 Oct; 5(10):754-7. PubMed ID: 1418840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast Na+-Li+ countertransport rate is elevated in essential hypertension.
    Zerbini G; Podesta F; Meregalli G; Deferrari G; Pontremoli R
    J Hypertens; 2001 Jul; 19(7):1263-9. PubMed ID: 11446716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal kinetics of erythrocyte sodium lithium countertransport in patients with diabetic nephropathy in Thailand.
    Vareesangthip K; Panthongdee W; Shayakul C; Nitiyanant W; Ong-Aj-Yooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S48-53. PubMed ID: 17044454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association study of sodium-lithium countertransport activity with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek dyslipidaemic patients and controls.
    Goulas A; Kosmidou M; Hatzitolios AI; Raikos N; Molyva D; Savopoulos C; Giannopoulos S; Fidani L
    Clin Chem Lab Med; 2008; 46(3):306-10. PubMed ID: 18254710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythrocyte sodium-lithium countertransport in diabetic adolescents].
    Guarena C; Boero R; Quarello F; Rolando B; Sacchetti C; Dianzani I; Maffei S; Cerutti F; Piccoli G
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1249-51. PubMed ID: 2124463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes.
    Vaccaro O; Cuomo V; Trevisan M; Cirillo M; Panarelli W; Laurenzi M; Mancini M; Riccardi G;
    Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Li(+)-Na+ countertransport by physiological levels of insulin in vitro.
    Foyle WJ; Drury PL
    J Hypertens; 1991 Aug; 9(8):713-7. PubMed ID: 1655881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible alteration of red cell lithium-sodium countertransport in patients with thyroid disease.
    Brent GA; Canessa M; Dluhy RG
    J Clin Endocrinol Metab; 1989 Feb; 68(2):322-8. PubMed ID: 2918049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Na-Li countertransport and risk of hypertension in children: a 10-year prospective study in Hanzhong children.
    Mu J; Liu Z; Yang D; Liang Y; Wang Z; Hou R
    J Hum Hypertens; 2004 Dec; 18(12):885-90. PubMed ID: 15269707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte Li-Na countertransport in hypertension: lack of atrial natriuretic peptide effect.
    Lau YT; Chern MS; Hung JS; Liang HC; Kao JF
    J Formos Med Assoc; 1991 Oct; 90(10):1022-6. PubMed ID: 1685169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of sodium-lithium countertransport activity to markers of cardiovascular risk in normotensive subjects.
    Hardman TC; Dubrey SW; Soni S; Lant AF
    J Hum Hypertens; 1995 Jul; 9(7):589-96. PubMed ID: 7562890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.